Organon & Co.
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
44.96%
Market Cap
3.03 Bil.
P/E Ratio
10.00
Dividend Yield
4.74 %
Earnings per Share
0.64 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 11.46 G | 0 Units |
| PRICE DETERMINATION TIME | 06/04/2026 / 09:05:56 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 11.46 | 11.42 |
| PREV. DAY'S PRICE | 11.53 | (06/03) |
| CHANGE DAY BEFORE | -0.07 | -0.61 % |
| 52 WEEK HIGH / LOW | 11.6 (05/21) | 4.957 (03/30) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 3.16 | 2.91 | 0.64 | 3.08 | 3.69 |
| DIVIDENDS PER SHARE | 0.07 | 0.07 | 0.30 | 1.04 | 1.04 |
| DIVIDEND YIELD IN % | - | - | 4.74 % | 7.51 % | 7.77 % |
| DIVIDEND GROWTH IN % | - | - | -70.89 % | -0.05 % | -2.73 % |
| PRICE - EARNINGS RATIO | 3.62 | 3.94 | 10.00 | 4.48 | 3.61 |
| PRICE - BOOK RATIO | - | - | 2.48 | 8.15 | - |
| PRICE - SALES RATIO | - | - | 0.30 | 0.60 | 0.59 |
| PRICE - CASH FLOW RATIO | - | - | 2.67 | 4.12 | 4.63 |
Master Data
| WKN | A3CPKP |
| ISIN | US68622V1061 |
| SYMBOL | 7XP |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | ORGANON + CO. DL -,01 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | 262.60 Mil. |
| MARKET CAPITALISATION | 3.03 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -0.26 % | 1.73 % | 86.77 % | 78.85 % | 44.96 % | -37.80 % | - | 98.74 % |
| HIGH | 11.53 | 11.60 | 11.60 | 11.60 | 11.60 | 21.57 | - | 11.60 |
| LOW | 11.33 | 11.12 | 4.96 | 4.96 | 4.96 | 4.96 | - | 4.96 |
Dividend
per share
Company profile
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.